Alternate Name:Pharmapure RX Esomep-EZS

Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.

Dosage Form:Capsule Delayed Release

Administration Route:By mouth

Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent

Generic Available:Yes

Strength:20 MG

Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools

Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.

PriapismThis medicine can cause a severe allergic reaction, especially in people allergic to warfarin. You can get a written response from your doctor or pharmacist if you are not sure.WarningsAllergyAllergy© 2013 John Wiley & Sons, Ltd. All Rights Reserved forapiocrehensiveoom.com Dispulates only with John Wiley & Wiley & Sons, Ltd. Code: 1349A-R-01Nexium Delayed-Release Capsules 40 mg Price per box

Starting Offer:$287.30 per 40 mg dose (30 capsules)Dosage Quantity:30 capsules (30 mg)

Quantity

30 capsules (30 mg) $287.30$6.

LONDON:The British drugmaker GlaxoSmithKline (GSK) on Tuesday reported a total gain of more than $1.5 billion in sales, after its biggest acquisition of $2.5 billion in cash and a $4.3 billion in debt.

The shares have gained more than 7 percent in price since the launch of its new cholesterol fighter Crestor, which had a market value of $30 billion in 2013.

But Glaxo's shares fell 5 percent on the market after the release of the patent for its cholesterol drug Nexium, which it had been testing on the market since 2007, but still faced stiff competition from a much weaker version of AstraZeneca's blockbuster heart drug Nexium, which had a market value of $20 billion in 2013.

Glaxo shares rose to $46.25, up 0.3 percent, on the open market and down 0.1 percent at the close.

GSK said it will pay about $1 billion upfront and expects that it will receive more than $600 million in payments to shareholders.

The company said it expects to pay a combined $600 million to $1 billion in cash and $1.5 billion in debt.

GSK said it has adjusted its debt and earnings forecasts for the next three years.

Glaxo shares rose 5 percent to $45.17 on the news.

A stock market of $6.1 billion in the United States was closed Monday but a third-quarter report was not available and a second-quarter report is due in June.

Glaxo said it has sold its $4.3 billion of debt to buy down the company's common stock and will continue selling the company's remaining shares in exchange for cash.

It said it has acquired 11,000 shares of the US stock exchange.

GK said it had reached an agreement to buy off its common stock in exchange for $2.1 billion.Shares of the company were down 1.2 percent on the New York Stock Exchange.

The company said it has completed an "advisendous" number of deals, which include buying and selling shares of the US stock exchange.

It is expected to close down the company's shares in the coming weeks and also sell its shares at a price lower than its current prices.

It said that the price of its US $6.5 million shares would be $1.9 to $3 per share. It also added that it would sell the stock at a price lower than its current price of $6 per share.

The company said it will sell its U. S. $6.8 million shares of the stock in a deal in early July, which would give the company more than $3 billion in cash and $3 billion in debt.

It said it has completed deals with three companies, including one that deals with the maker of a copy of its cholesterol drug Crestor, and has acquired the rights to sell it at a lower price than its current price.

In the United States, the U. stock market was closed Monday at $3.75 per share, but a third-quarter report was not available.

GSK said it expects to pay a combined $600 million to $600 million to buy down its common stock in the coming years, which it will sell and sell at a price lower than its current price.

The company said it will pay a combined $600 million to $600 million to buy down the company's common stock in the next two years, which it will sell and sell at a price lower than its current price.

The company said it has reached an agreement with the US equity partners to sell its stock in exchange for $600 million in a $2 billion transaction, which will give it more than $3 billion in cash and $3 billion in debt.

GSK said it has completed deals with nine companies, including one that deals with the maker of a copy of its cholesterol drug Crestor, and has acquired the rights to sell it at a lower price than its current price.

GSK said it has sold its $600 million to buy down the company's common stock in the US.

It said it had reached an agreement with the US equity partners to sell its $600 million to buy down the company's common stock in the US.

GSK said it has reached an agreement with the U. S equity partners to sell its stock in the United States, and has agreed to sell its shares at a price lower than its current price.

The store will not work correctly when cookies are disabled.

JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.

Nexium 24 Hour 20mg 14 TabletsShopping Cart is Empty

Lasting relief for frequent heartburn and acid reflux.

Always read the label and follow the directions for use.

Nexium 24HR 20 mg enteric coated tablets for the lasting symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux.

Always take this medicine exactly as described in the Consumer Medicine Information leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is one tablet a day. - Do not take more than this recommended dose of one tablet (20 mg) a day, even if you don't feel an improvement immediately. - You may need to take Nexium 24HR for a few days before experiencing the full effect. - Nexium 24HR should be taken for at least 7 days and up to 14 days. - Tell your pharmacist or doctor if you do not feel better while taking Nexium 24HR. If symptoms persist or recur within 2 weeks of completing the course, consult your doctor. Further examination may be required.

Always read the label, use only as directed. Tell your pharmacist or doctor if you notice any of the following and they worry you: nausea or vomiting, constipation, diarrhoea, headache, wind, stomach pain, skin rash, itchy skin, dizziness or dry mouth. These side effects are usually mild. Tell your pharmacist or doctor if you are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop. Some medicines may interfere with Nexium 24HR. Do not take Nexium 24HR if you are pregnant unless your doctor says so. Ask your doctor about the risks and benefits involved. It is not known if it is safe for you to take Nexium 24HR while you are pregnant. It may affect your baby. Do not take Nexium 24HR if you are breastfeeding. Ask your doctor for more information. It is not known if Nexium 24HR is excreted in breastmilk if you are breastfeeding.

Canesten cap 20mg + 20mg granule mg Nexium 24HR salutamine esterCanesten cap 40 mg Nexium 24HR salutamine ester

Always take this medicine exactly as described in the Consumer Medicine Information leaflet or as your doctor have told you. Read the Consumer Medicine Information leaflet that comes with this medicine. If any of this is not clear, tell your doctor or pharmacist. This medicine is in wrong class. Acid reflux medicines: this class contains medicines called H2 blockers and these are used to treat heartburn, acid regurgitation and other symptoms of acid reflux, e.g. constipation, diarrhoea. This medicine does not work for children under the age of 8 years. Acid reducer medicines: this class contains amylase and butyl_____ which are medicines used to treat gastro-oesophageal reflux (GORD) e.g. Zylose. These medicines work by blocking stomach acid circulation and reducing stomach acid production. Esomeprazole is a member of this group. Common cold medicine for colds and famciclovir is cidofovir, a human immunodeficiency virus glycoside. Nafcillin and clarithromycin are members of this group. Antibiotics: this group includes erythromycin, imipramine, meropenem and ertapenem. Quinine and proton pump inhibitors (e.g. doxazosin, quinidine) are members of this group. If you are sexually active after 7 days of having sex, do not take this medicine. You should not take this medicine if you are allergic to esomeprazole or any of the other ingredients of this medicine. Omeprazosin is a medicine used to treat nausea and vomiting. Omeprazosin does not work for children under the age of 6. Amoxicillin is a medicine used to treat bacterial infections (e.g. tooth infection, periodontitis). It may also work for you by reducing the activity of the microbe that causes acid secretion (neurosporum). This medicine does not work for colds and famciclovir e.g.

The drugmaker will be the first to report its $3.7 billion annual revenue, and the largest company in the world, a top-selling drug, is going generic. The rest of the world will follow, according to a new report from Bloomberg.

Analysts expect the first-quarter profit of $7 billion to $8.9 billion.

The second-quarter profit was $2.2 billion, up 11 percent, from $2.7 billion.

The company said it expects its net earnings for the second quarter to be in the range of $0.7 billion to $0.9 billion.

The company said it expects its revenue growth of 5 percent to 6 percent to be between $1.3 billion and $1.6 billion.

The report also said earnings growth would be between 11 percent and 13 percent, while earnings per share would be between 4 percent and 6 percent.

The report also noted earnings were up 7 percent, to $1.2 billion, and to $0.2 billion, to $0.4 billion, and to $0.3 billion, to $0.4 billion, and to $0.3 billion, to $0.3 billion, and to $0.3 billion, to $0.3 billion, to $0.3 billion.

The company said it expects a net loss of $0.7 billion, and expects the company to earn about $0.6 billion this year.

The report, which was released in a March 30, showed sales growth of 8 percent in the second quarter.

The company said it is also looking at other products that have increased in the second quarter, including an antidepressant drug. Analysts expect that the company will make its final decision on a new drug this year.

Pipeline Pharma is a biopharmaceutical company based in Mountain View, California. Its main product is Nexium, a treatment for heartburn and acid reflux. The company also has a biosimilar Nexium Capsule, which can be used to treat acid reflux, stomach ulcers and to relieve stomach pain. The company also has an antacid product, called Nexium 24HR, which contains 24.3 mg of acid per 1,000 milliliters.

The company said it expects to sell 1.4 million units of the company's product line, which includes Nexium 24HR. The company also has a biotechnology company, Teva Pharmaceuticals Inc., which is developing a drug that is used to treat high blood pressure. The company is in the process of developing a novel drug to treat heartburn and acid reflux.

Analysts at Thomson BFAQs and BFAQS are writing to the companies to explore new opportunities for the stock.

Source-E-Business

Consumer Reports

Get your free, monthly report from theConsumer Reports Research Analyst & Analyst Network

Consumer Reports Research Analyst and Analyst Network:

Consumer Reports Research Analyst & Analyst NetworkConsumer Reports Analyst & Analyst NetworkYourCall.